Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-26-006103

CEO sold 523 shares at $87.92 ($45,982)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Zovighian Bernard J CEO 2026-06-17 Sale 10b5-1 −523 $87.92 $45,982 11,516.55 I: show line 1 in the form
Open-market sales · 523 sh · avg $87.92 · $45,982
Loading xslF345X06/doc4.xml…